Related articles

• DEC1 promotes breast cancer bone metastasis through transcriptional activation of CXCR4
  DOI: 10.7555/JBR.39.20250031
• Drug resistance mechanisms in cancers: Execution of pro-survival strategies
  2024, 38(2): 95-121. DOI: 10.7555/JBR.37.20230248
• Insulin receptor is implicated in triple-negative breast cancer by decreasing cell mobility
  2021, 35(3): 189-196. DOI: 10.7555/JBR.34.20200082
• RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer
  2020, 34(2): 129-138. DOI: 10.7555/JBR.34.20190111
• miR-3622b-5p regulates cisplatin resistance of human gastric cancer cell line by targeting BIRC5
  2019, 33(6): 382-390. DOI: 10.7555/JBR.33.20180078
• Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer
  2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065
• Preparation, optimization, and characterization of chitosancoated solid lipid nanoparticles for ocular drug delivery
  2018, 32(6): 411-423. DOI: 10.7555/JBR.32.20160170
• Herpes zoster in breast cancer: a case report
  2017, 31(4): 370-372. DOI: 10.7555/JBR.31.20170009
• Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer patients
  2013, 27(6): 478-485. DOI: 10.7555/JBR.27.20130021
• STAT3 mediates resistance of CD44+CD24-/low breast cancer stem cells to tamoxifen in vitro
  2012, 26(5): 325-335. DOI: 10.7555/JBR.26.20110050